The Philippines Biosensors Market was valued at $63.6 Mn in 2023 and is predicted to grow at a CAGR of 8.5% from 2023 to 2030, to $112.5 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, emphasis on preventative care, and increasing demand for accurate disease diagnosis. The prominent players of the Philippines Biosensors Market are Medev Medical Devices Corporation, Masimo Corporation, Meridian Bioscience, Biosensors International, Progressive Medical Corporation, and Abbott Laboratories, among others.
Philippines LASIK Surgery Market was valued at $7.77 Mn in 2023 and is predicted to grow at a CAGR of 5.71% from 2023 to 2030, to $11.46 Mn by 2030. The key drivers of this industry include Market is therefore driven by significant factors like the rising prevalence of vision problems, growing economy, and expanding ophthalmology market. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
The Philippines Medical Digital Imaging System Market was valued at $67.1 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $120.32 Mn by 2030. The key drivers of this industry include healthcare expenditure, increasing healthcare infrastructure, and technological advancements. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
Philippines Breastfeeding Accessories Market was valued at $5.52 Mn in 2023 and is predicted to grow at a CAGR of 7.30% from 2023 to 2030, to $9.04 Mn by 2030. The key drivers of this industry include government initiatives and policies, an increasing number of working mothers, and technological advancements. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
The Philippines Central Nervous System (CNS)Therapeutics Market was valued at $462 Mn in 2022 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $788 Mn by 2030. The key drivers of this industry include the rising prevalence of CNS disorders, increasing healthcare infrastructure, and expanding pharmaceutical landscape. The industry is primarily dominated by players such as Abbott, Novartis, Merck, Eisai, AstraZeneca, United Laboratories, and CIG Philippines among others.